(Image: Getty/CIPhotos)

Evotec licenses Ncardia’s disease modeling patents

By Melissa Fassbender

Ncardia has entered into a non-exclusive licensing agreement with Evotec through which the drug discovery solutions company will gain access to Ncardia’s stem cell derived cellular disease modeling IP.

The decision has implications for all CMOs and those companies with whom they partner. (Image: iStock/Zerbor)

The patent lives in Hospira v MedCo: good news for CMOs

By Melissa Fassbender

The Medicines Company announced last week that its Angiomax patent has been upheld – an 'important court decision' which affirms that working with CMOs won’t invalidate a company's patent.

The US Patent and Trademark Office and case law have created confusion around IP

Sequenom case leaves pharma confused over patent law

By Fiona BARRY

US intellectual property (IP) rules and a string of recent court cases are reducing the types of inventions pharma companies can patent, and “calling into question entire portfolios,” says a specialist lawyer. 

Industry news in brief

Industry news in brief

By Dr Matt Wilkinson presents its periodic round up of recent
industry news with new developments at Agilent, Beckman Coulter,
Carl Zeiss, DuPont, Luminex and PerkinElmer.


Follow us


View more


Featured Suppliers